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AnthracyclinesAbstract Background: Anaesthetics and anthracyclines can affect the QT interval of the electrocar-
diogram (ECG). This study investigated whether the use of isoﬂurane in anthracyclines pretreated
patients may induce or augment the QT prolongation to an arrhythmogenic level.
Materials and methods: Fifty-four female patients with breast cancer scheduled for mastectomy were
included in the study, 27 received anthracyclines based chemotherapy before surgery, whereas 27 did
not. All patients received a standardized balanced anaesthetic in which 0.5% end tidal concentration
of isoﬂurane was used. The QT and corrected QT intervals (QTc) were measured before anaesthesia,
after 1, 5, 15, 30, 60 min, respectively, following intubation and during recovery from anaesthesia.
Results: Statistically signiﬁcant QTc prolongation was observed in patients who received anthracy-
cline chemotherapy even prior to the administration of anaesthesia. The comparison of QTc interval
at different intervals of isoﬂurane anaesthesia also showed a statistically signiﬁcant difference between
the two groups namely anthracycline treated group (study group) versus control group.
A sample size of 27 in each group was calculated in order to achieve a study power of 80%with type 1
error rate of 5%.For thepurpose of calculation, values ofQTandQTc interval (range,mean, standard
deviation) from the study of Owczuk et al. were used. t-test and analysis of variance were employed
using SPSS version 10. P< 0.05 was considered as statistically signiﬁcant.
Conclusions: Anthracycline chemotherapy can produce signiﬁcant prolongation of QTc interval. In
addition, use of 0.5% end tidal concentration of isoﬂurane can further augment the QTc interval sig-
niﬁcantly.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
Chemotherapy forms an important adjuvant for the treatment
of breast cancer. Anthracyclines especially doxorubicin is a
commonly employed chemotherapeutic agent which can pro-
long the QT interval in susceptible individuals [1]. Isoﬂurane,
one of the most commonly used inhalational anaesthetic agent
for maintenance of anaesthesia, is also shown to prolong the
QT interval [2]. Prolongation of the QT interval is associated
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dose dependent prolongation of the QT interval is a marker of
post anthracyclines cardio toxicity [1,5,6]. Earlier studies have
shown that Propofol, which was used for induction of anaes-
thesia, tends to shorten the QT interval [7,8]. The effect of in-
creased heart rate on QT interval has been overcome by using
correction of QT interval for heart rate (QTc) by (Bazett’s
[9,10] and Fridericia’s formulae [11].
In this context, a study was conducted in our institute to
investigate whether the addition of Isoﬂurane to the anaes-
thetic regimen in anthracycline pretreated patients would pro-
long the QT interval to an arrhythmogenic level and to assess
the effect of isoﬂurane on the haemodynamic variables (blood
pressure and heart rate) of the patients under study. Propofol
was used as the induction agent, which may limit the QT pro-
longation produced by isoﬂurane.
2. Materials and methods
After obtaining approval from the institutional review board
and ethics committee, 54 women aged 30–60 years of ASA
(American Society of Anaesthesiologists) 1 and 2 statuses
scheduled for mastectomy were enrolled in the study.
Twenty-seven patients received anthracycline chemotherapeu-
tic agents (study group) and 27 patients did not receive any
such treatment before surgery (control group). Patients were
excluded from the study if they received class 1 or 3 antiar-
rhythmics and had any history of heart disease, hypertension
or any circulatory insufﬁciency. Patients receiving psychotro-
pic or other drugs known to prolong the QT interval or having
any preoperative electrolyte abnormalities, signiﬁcant arrhyth-
mias, or conduction disturbances in the preoperative ECG
were also excluded. Diabetics included in the study were con-
trolled with regular insulin if they were previously on oral
hypoglycaemic agents.
All patients included in the study group underwent a detailed
preanaesthetic check-up, a cardiology evaluation including
echocardiography. The age, weight, baseline heart rate, systolic
anddiastolic bloodpressureswere noted.ThepreoperativeECG
ﬁndings were recorded. Written informed consent was obtained
from all the patients. They received tablet diazepam 0.2 mg/kg
bodyweight and tablet ranitidine 150 mg the night before sur-
gery and tablet ranitidine 150 mg and tablet metoclopramide
10 mg at 6.00 am on day of surgery following overnight fasting.
After the machine check and preparation of the operation
theatre, an ECG was taken in the reception area and the time,
blood pressure and the heart rate were noted. An intravenous
access was secured, and ﬂuid infusion started with 0.9% nor-
mal saline and then shifted to the operating room in a trolley.
1 mg of midazolam was given, and monitors were attached –
ECG, non invasive blood pressure (NIBP), pulse oximetry
(SPO2) and baseline values obtained in the multiparameter
monitor. The electrodes for recording the lead 2 of ECG were
also attached.
The patients were preoxygenated with 100% oxygen for
3 min and intravenous fentanyl 2 lg/kg bodyweight was given
5 min before laryngoscopy. General anaesthesia was induced
with intravenous propofol 2 mg/kg bodyweight. The adequacy
of mask ventilation was conﬁrmed and vecuronium 0.1 mg/kg
bodyweight was given and the time noted. Anaesthesia main-
tained with nitrous oxide oxygen mixture at a ratio of 2:1 at6 l/min fresh gas ﬂow. At 1.5 min after giving the relaxant
intravenous lidocaine, 2% was given at a dose of 1.5 mg/kg
body weight for stress response attenuation. Direct laryngos-
copy with appropriate sized Macintosh blade was carried out
and the trachea intubated with an appropriate sized cuffed
oral endotracheal tube. The endotracheal tube was secured
after conﬁrming the position of the tube by auscultation
and end tidal carbon dioxide (ETCO2). Soon after intuba-
tion, an ECG was obtained and anaesthesia was maintained
using nitrous oxide oxygen in 2:1 ratio at fresh gas ﬂow of
3 l/min and isoﬂurane in a concentration of 0.5% by volume.
ECGs were obtained at 1 min of anaesthesia with isoﬂurane
0.5% and then at regular intervals of 5, 15, 30 and 60 min
of anaesthesia. During the whole period of ECG recording,
the end tidal isoﬂurane concentration was monitored in the
anaesthesia workstation and was kept at 0.5%. Near the
end of surgery, the isoﬂurane concentration was reduced
and discontinued at beginning of skin closure. Following
reversal of neuromuscular block with neostigmine 0.05 mg/
kg body weight and glycopyrrolate 0.01 mg/kg bodyweight,
trachea was extubated and another ECG-lead 2 was obtained
in the recovery room.
The QT and corrected QT intervals (QTc) were measured
before anaesthesia, after 1, 5, 15, 30, 60 min, respectively, fol-
lowing intubation and during recovery from anaesthesia. QTc
were calculated using Bazett’s [9,10] and Fridericia’s formulae
[11].
3. Results
All patients in the study group received adriamycin with 21 pa-
tients received 6 cycles and 6 patients received 5 cycles. The to-
tal cumulative dose received by the study patients ranged from
250 mg/m2 to 300 mg/m2 body surface area. The age and body
weight were similar in both the groups (p> 0.05). The QT
interval showed statistically signiﬁcant differences even at
baseline and subsequently at different intervals of anaesthesia
between the study and control groups. In the study group
(anthracycline group), signiﬁcant prolongation of QT interval
was observed. The mean (SD) baseline values of QT for con-
trol and study groups were 0.27 (0.03) and 0.37 (0.03) respec-
tively (p-value = 0.001). In the control group, the mean values
of QT interval at different time intervals of anaesthesia in-
creased to 0.29 s, whereas the corresponding values in the
study group increased to 0.42 s, which exceeded the normal va-
lue of 0.40 s. The augmentation of QT prolongation produced
by isoﬂurane was proportional in both the control and study
group (Table 1).
Similar to QT interval, QTc interval based on both Bazett’s
and Fridericia’s formulae also showed statistically signiﬁcant
differences at baseline and subsequently at different intervals
of anaesthesia between the study and control groups. The
mean (SD) baseline values of QTc based on Bazett’s formula
for control and study groups were 0.30 (0.03) and 0.46
(0.05), respectively (p-value = 0.001). In the control group,
the mean values of the QTc interval at different time intervals
increased to 0.34 s, whereas the corresponding values in the
study group increased to 0.48 s which exceeded the normal va-
lue of 0.44 s. Similar to QT interval, the augmentation of QTc
prolongation produced by isoﬂurane was proportional in both
the control and study group (Table 2).
Table 1 Comparison of QT at baseline and at different intervals of anaesthesia.
Time Control group (n= 27) Study group (n= 27) p-Value
Mean SD Mean SD
Baseline 0.27 0.03 0.37 0.03 0.001*
After induction and intubation 0.29 0.03 0.38 0.03 0.008*
After 1 min 0.29 0.03 0.39 0.03 0.0001*
After 5 min 0.28 0.03 0.40 0.03 0.0001*
After 15 min 0.28 0.03 0.41 0.03 0.0001*
After 30 min 0.29 0.03 0.41 0.03 0.0001*
After 60 min 0.29 0.04 0.42 0.03 0.0001*
Recovery 0.29 0.03 0.40 0.03 0.0001*
* Statistically signiﬁcant at 0.01 level.
Table 2 Comparison of QTc based on Bazett’s formula at baseline and at different intervals of anaesthesia.
Time Control group (n= 27) Study group (n= 27) p-Value
Mean SD Mean SD
Baseline 0.30 0.03 0.46 0.05 0.001*
After induction and intubation 0.34 0.04 0.48 0.04 0.007*
After 1 min 0.34 0.05 0.48 0.03 0.0001*
After 5 min 0.33 0.05 0.47 0.03 0.0001*
After 15 min 0.32 0.04 0.47 0.03 0.0001*
After 30 min 0.32 0.04 0.47 0.03 0.0001*
After 60 min 0.32 0.04 0.46 0.04 0.0001*
Recovery 0.32 0.04 0.47 0.04 0.0001*
* Statistically signiﬁcant at 0.01 level.
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formula for control and study groups were 0.29 (0.03) and 0.43
(0.04), respectively (p-value = 0.001). In the control group, the
mean values of the correspondingQTc intervals at different time
intervals increased to 0.32 s, whereas the corresponding values
in the study group increased to 0.45 s as against 0.48 s according
to Bazett’s formula. The augmentation of the QTc prolongation
produced by isoﬂuranewas proportional in both the control and
study group using Fridericia’s formula also (Table 3).
Table 4 summarizes the number of patients in whom the
QTc value exceeded the reference value of 0.44 s during the
course of study. There was a signiﬁcant prolongation of QTc
interval in the study group both before induction of anaesthe-
sia, during anaesthesia and during recovery. Only 3.7% of con-
trol group patients had a prolongation of QTc after induction
and intubation and after 1 min (1 patient). Only two patients
showed an increase in QTc interval at 5 min of anaesthesia.Table 3 Comparison of QTc based on Fridericia’s formula at base
Time Control
Mean Sd
Baseline 0.29 0.0
After induction and intubation 0.32 0.0
After 1 min 0.32 0.0
After 5 min 0.31 0.0
After 15 min 0.30 0.0
After 30 min 0.31 0.0
After 60 min 0.31 0.0
Recovery 0.31 0.0The highest percentage of QTc prolongation occurred after
induction and at 15 min of anaesthesia (81.5%). Table of dis-
tribution of prolonged QTc showed a consistently high per-
centage in the study group.
The baseline value of heart rate of patients in the study
group was statistically signiﬁcant (p< 0.01) as compared to
the patients in control group. The mean (SD) baseline values
of heart rate per minute for control and study groups were
77.9 (6.2) and 83.6 (9.3), respectively (p-value = 0.01). How-
ever, during the course of anaesthesia, there was no statistical
difference between the heart rates in both the groups.
After induction and intubation, there were no signiﬁcant
differences between the two groups with regard to the systolic,
diastolic and mean arterial pressures. No signiﬁcant difference
between the systolic, diastolic and mean arterial pressures be-
tween the two groups during the rest of the anaesthetic period
(data not shown).line and at different intervals of anaesthesia.
Study p-Value
Mean Sd
3 0.43 0.04 0.001\
4 0.44 0.03 0.001\
4 0.44 0.03 0.001\
4 0.45 0.03 0.001\
4 0.45 0.03 0.001\
4 0.45 0.03 0.001\
4 0.45 0.03 0.001\
4 0.44 0.03 0.001\
Table 4 Distribution of prolonged QT interval (QTc > 0.44).
Time Control group Study group
No. of patients Percentage No.of patients Percentage
Baseline 0 0.0 18 66.7
After induction and intubation 1 3.7 22 81.5
After 1 min 1 3.7 21 77.8
After 5 min 2 7.4 21 77.8
After 15 min 0 0.0 22 81.5
After 30 min 0 0.0 20 74.1
After 60 min 0 0.0 19 70.4
Recovery 0 0.0 22 81.5
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The main ﬁnding of this study was that patients who have re-
ceived anthracyclines based chemotherapy (study group) were
more prone to develop prolongation of QT interval during
administration of isoﬂurane anaesthesia compared to the con-
trol group. The QT interval shortens with increasing heart rate
[12]. Therefore, heart rate corrected QT interval or ‘QTc’ is
used to study the cardiac depolarization. QTc is the QT inter-
val that would be observed in the same ECG if the heart rate
was 60 beats per minute, i.e. R–R interval is 1 s [13]. Many
methods have been developed to calculate QTc. In practice,
the QT interval is expressed as a ‘corrected QT (QTc)’ dividing
the QT interval by the square root of the R–R interval (interval
between ventricular depolarization). QTcB = QT/
p
RR inter-
val (Bazett’s formula) [9,10] where QTc is the QT interval cor-
rected for heart rate, and RR is the interval from the onset of
one QRS complex to the onset of the next QRS complex.
According to Fridericia’s formula [11], QTc is obtained by
dividing the QT interval by the cube root of RR interval, i.e.
QTcF = QT/cube root of RR interval. In the present study,
we used both the formulae to overcome the effect of increased
heart rate on QT interval. They assume an exponential rela-
tionship between QT and RR interval. This was in accordance
with the International Conference on Harmonization (ICH)
document published in 2005 (E 14 Clinical evaluation of QT/
QTC Interval Prolongation and Proarrhythmic Potential for
Non-Antiarrhythmics Drugs) [14]. This allows an assessment
of the QT interval that is independent of heart rate. Normal
corrected QTc intervals are less than 0.44 s and considered to
be prolonged if more than 0.44 s, based on the reports of Owc-
zuk et al. [15]. This conﬁrms other studies quoting QTc prolon-
gation as a marker of postanthracycline cardio toxicity
[5,6,16,17]. This was in contrast to the ﬁnding of Owczuk
et al. [15] who found no statistical difference in the QT inter-
vals between the two groups. The study population in the pres-
ent study received a higher total dose of anthracyclines than
that of the study of Owczuk et al. [15], and this may account
for the difference in baseline QT intervals seen between the
two studies. Larsen R L et al. [5] reports the prolongation of
QT interval after a cumulative dose of anthracyclines of
282 mg/m2 body surface area.
In the present study, the QTc at different intervals of isoﬂu-
rane anaesthesia based on both the formulae also showed a
statistically signiﬁcant difference between the two groups.
The increase in QTc interval from baseline occurred for both
the control and the study groups but for the control group itwas statistically insigniﬁcant. The mean QTc in the study
group ranged from 0.46 to 0.48 s based on Bazett’s formula.
However, according to Fridericia’s formula, the corresponding
values ranged only from 0.43 to 0.45. This is due to difference
in the formula as Bazett’s formula used square root of RR
interval, whereas the Fridericia’s formula used the cube root
of RR interval. Even though Fridericia’s formula showed less
difference, at some points of time, the QTc prolongation was
more than the reference value of 0.44 s based on studies from
Khan [3] and Wisely and Shipton [18].
The ﬁnding of statistically prolonged QTc interval in the
study group was consistent with that from the study of Owc-
zuk et al. [15] The QTc values were more prolonged in the pres-
ent study than the study of Owczuk et al. [15]. Michaloudis
et al. [2] reported that Isoﬂurane anaesthesia statistically pro-
longs the QTc interval. The increase in QTc interval after lar-
yngoscopy and intubation can be attributed to the increased
plasma concentrations of catecholamines. This ﬁnding has
been made by Yee et al. [19] which proposed that the increase
in QT interval after intubation might be due to an increase in
catecholamines which increases the after load of the heart. In
the present study, no value of QTc exceeded the 0.6 s which
is suggested as the level for signiﬁcant arrhythmia generation.
In a study of the time dependent cumulative effects of three
inhalational anaesthetics on QTc interval by Karagoz et al.
[20], it was found that although 1% isoﬂurane produced higher
QTc values than halothane and sevoﬂurane, none of them pro-
duced critical value of 0.44 s. In the present study, signiﬁcant
increase in QTc interval was observed although only 0.5% iso-
ﬂurane was used.
The baseline heart rate in the present study was higher for
the study group of patients. The range of heart rate for the
study population was 74–93 beats per minute. This is in con-
trast to the control group whose heart rates ranged from 71
to 83 beats per minute. Booker et al. [9] reviewed that the
QT interval varies with heart rate, lengthening with bradycar-
dia and shortening with increased rates. This was not observed
in the present study. In this study, the baseline heart rate of the
study population was higher and the baseline QT was also pro-
longed. But after induction of anaesthesia, the QT further pro-
longed and the heart rate decreased.
The main limitation of the present study was the use of pro-
pofol for induction of anaesthesia, which was cited by Kleins-
asser et al. [7] in their study to signiﬁcantly shorten the QT but
not the QTc interval. The ﬁnding of Kleinsasser et al. [7] has
been reinforced in the study done by Paventi et al. [8].
Saarnivaara et al. [21] found a shortening of QTc interval with
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study was that the use of propofol could have mitigated undue
prolongation of the QTc interval to the arrhythmogenic
potential of 0.6 s.
In the present study, although QTc is prolonged, the use of
combination of anaesthetic agents such as propofol and isoﬂu-
rane might have helped to prevent generation of arrhythmias.
During no point of time of anaesthesia, any signiﬁcant
arrhythmia was observed. The only arrhythmia that occurred
during anaesthesia with no statistical signiﬁcance was an occa-
sional extra systole observed in two patients who received
anthracycline chemotherapy. The heart rates and mean arterial
blood pressures showed no signiﬁcant change during
anaesthesia.
In conclusion, anthracyclines especially doxorubicin pro-
duce statistically signiﬁcant QTc prolongation. The use of iso-
ﬂurane for maintenance of anaesthesia in such patients further
augments the QTc prolongation. Hence, if at all used its use
for maintenance of anaesthesia in such patients should be care-
fully monitored and kept below 1% for patient safety. The
augmentation of QTc prolongation produced by isoﬂurane is
proportional in both the control and study groups.
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